HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases.

Abstract
Fas (CD95) triggers programmed cell death and is involved in cell-mediated cytotoxicity and in shutting off the immune response. Inherited loss-of-function mutations hitting the Fas system cause the autoimmune/lymphoproliferative syndrome (ALPS). We have recently shown that ALPS patients' families display increased frequency of common autoimmune diseases, including type 1 diabetes. This work evaluates Fas function in type 1 diabetic patients without typical ALPS. Cell death induced by anti-Fas monoclonal antibody was investigated in T-cells from 13 patients with type 1 diabetes alone and 19 patients with type 1 diabetes plus other autoimmune diseases (IDDM-P). Moreover, we analyzed 19 patients with thyroiditis alone (TYR), because most IDDM-P patients displayed thyroiditis. Frequency of resistance to Fas-induced cell death was significantly higher in patients with IDDM-P (73%) than in type 1 diabetic (23%) or TYR (16%) patients or in normal control subjects (3%). The defect was specific because resistance to methyl-prednisolone-induced cell death was not significantly increased in any group. Fas was always expressed at normal levels, and no Fas mutations were detected in four Fas-resistant IDDM-P patients. Analysis of the families of two Fas-resistant patients showing that several members were Fas-resistant suggests that the defect has a genetic component. Moreover, somatic fusion of T-cells from Fas-resistant subjects and the Fas-sensitive HUT78 cell line generates Fas-resistant hybrid cells, which suggests that the Fas resistance is due to molecules exerting a dominant-negative effect on a normal Fas system. These data suggest that Fas defects may be a genetic factor involved in the development of polyreactive type 1 diabetes.
AuthorsS DeFranco, S Bonissoni, F Cerutti, G Bona, F Bottarel, F Cadario, A Brusco, G Loffredo, I Rabbone, A Corrias, C Pignata, U Ramenghi, U Dianzani
JournalDiabetes (Diabetes) Vol. 50 Issue 3 Pg. 483-8 (Mar 2001) ISSN: 0012-1797 [Print] United States
PMID11246866 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • fas Receptor
Topics
  • Adolescent
  • Adult
  • Antibodies, Monoclonal (pharmacology)
  • Autoimmune Diseases (complications)
  • Cell Death (drug effects, physiology)
  • Cell Line
  • Child
  • Diabetes Mellitus, Type 1 (complications, genetics, physiopathology)
  • Drug Resistance
  • Female
  • Humans
  • Male
  • Mutation
  • Reference Values
  • T-Lymphocytes (immunology, physiology)
  • Thyroiditis (physiopathology)
  • fas Receptor (analysis, genetics, immunology, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: